319
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

A critical review finds styrene lacks direct endocrine disruptor activity

, , , &
Pages 727-764 | Received 16 Oct 2014, Accepted 16 Jun 2015, Published online: 19 Aug 2015

References

  • Agrawal AK, Srivastava SP, Seth PK. (1982). Effect of styrene on dopamine receptors. Bull Environ Contam Toxicol, 29, 400–3.
  • Alexander M. (1997). Enviromental fate and effects of styrene. Crit Rev Environ Sci Technol, 27, 383–410.
  • Arfini G, Mutti A, Vescovi P, Ferroni C, Ferrari M, Giaroli C, et al. (1987). Impaired dopaminergic modulation of pituitary secretion in workers occupationally exposed to styrene: Further evidence from PRL response to TRH stimulation. J Occup Med, 29, 826–30.
  • Arnetz BB. (1996). Techno-stress: a prospective psychophysiological study of the impact of a controlled stress-reduction program in advanced telecommunication system design work. J Occup Med, 38, 53–65.
  • ATSDR. (2010). Toxicological profile for styrene. US department of health and human services. Public health service. Agency for toxic substances and disease registry. November 2010.
  • Azuma Y, Nobuhara Y, Date K, Ohno K, Tanaka K, Hirano S, et al. (2000). Biological evaluation of styrene oligomers for endocrine-disrupting effects. J Food Hygienic Soc Japan, 41, 109–15.
  • Bagdy G, Arato M. (1987). Serum dopamine-ß-hydroxylase activity and alcohol withdrawal symptoms. Drug Alcohol Depend, 19, 45–50.
  • Balcombe JP, Barnard ND, Sandusky C. (2004). Laboratory routines cause animal stress. Contemp Top Lab Anim Sci, 43, 42–51.
  • Beliles RP, Butala JH, Stack CR, Makris S. (1985). Chronic toxicity and three-generation reproduction study of styrene monomer in the drinking water of rats. Fund Appl Toxicol, 5, 855–68.
  • Berg M, Arnetz BB, Liden S, Eneroth P, Kallner A. (1992). Techno-stress: a psychophysiological study of employees with VDU-associated skin complaints. J Occup Med, 34, 698–701.
  • Bergamaschi E, Mutti A, Cavazzini S, Vettori MV, Renzulli FS, Franchini I. (1996). Peripheral markers of neurochemical effects among styrene-exposed workers. Neurotoxicol, 17, 753–60.
  • Bergamaschi E, Smargiassi A, Mutti A, Cavazzini S, Vettori MV, Alinovi R, et al. (1997). Peripheral markers of catecholamine dysfunction and symptoms of neurotoxicity among styrene-exposed workers. Int Arch Occup Environ Health, 69, 209–14.
  • Biondi M, Picardi A. (1999). Psychological stress and neuroendocrine function in humans: the last two decades of research. Psychother Psychosom, 68, 114–50.
  • BKH. (2000). European Commission DG ENV. Towards the establishment of a priority list of substances for further evaluation of their role in endocrine disruption - preparation of a candidate list of substances as a basis for priority setting. BKH Consulting Engineers, Delft, The Netherlands.
  • Boobis AR, Doe JE, Meek ME, Munn S, Ruchirawat M, Schlatter J, et al. (2008). IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans. Crit Rev Toxicol, 38, 87–96.
  • Borgert CJ, Mihaich EM, Ortego LS, Bentley KS, Holmes CM, Levine SL, Becker RA. (2011). Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's endocrine disruptor screening program. Regul Toxicol Pharmacol, 61, 185–91.
  • Borgert CJ, Mihaich EM, Quill TF, Marty MS, Levine SL, Becker RA. (2011a). Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results. Reg Toxicol Pharmacol, 59, 397–411.
  • Borgert CJ, Stuchal LD, Mihaich EM, Becker RA, Bentley KS, Brausch JM, et al. (2014). Relevance weighting of tier 1 endocrine screening endpoints by rank order. Birth Defects Res (Part B), 101, 90–113.
  • Bruhn T, Ludewig S, Gülden M, Seibert H. (1998). Einstufung von Schadstoffen als endokrin wirksame Substanzen. Forschungsbericht 297 61 001/08 im Auftrag des Umweltbundesamts.
  • Butcher RL, Collins WE, Fugo NW. (1974). Plasma concentrations of LH, FSH, prolactin, progesterone and estradiol-17ß throughout the 4-day estrous cycle of the rat. Endocrinology, 94, 1704–8.
  • Campo P, Loquet G, Blachere V, Roure M. (1999). Toluene and styrene intoxication route in the rat cochlea. Neurotoxicol Teratol, 21, 427–34.
  • CEFIC submission. (2000). Collection of substance specific data for styrene. Submission to EU 20th July 2000.
  • Chakrabarti SK. (1999). Styrene and styrene oxide affect the transport of dopamine in purified rat striatal synaptic vesicles. Biochem Biophys Res Commun, 255, 70–4.
  • Chakrabarti SK. (2000). Altered regulation of dopaminergic activity and impairment in motor function in rats after subchronic exposure to styrene. Pharmacol Biochem Behavior, 66, 523–32.
  • Chamkhia N, Sakly M, Rhouma KB. (2006). Male reproductive impacts of styrene in rat. Toxicol Ind Health, 22, 349–55.
  • Chapin RE, Creasy DM. (2012). Assessment of circulating hormones in regulatory toxicity studies II. Male reproductive hormones Toxicol Pathol, 40, 1063–78.
  • Checkoway H, Costa LG, Camp J, Coccini T, Daniell WE, Dills RL. (1992). Peripheral markers of neurochemical function among workers exposed to styrene. Brit J Ind Med, 49, 560–5.
  • Checkoway H, Echeverria D, Moon JD, Heyer N, Costa LG. (1994). Platelet monoamine oxidase B in workers exposed to styrene. Int Arch Occup Environ Health, 66, 359–62.
  • Coccini T, Randine G, Li B, Manzo L, Costa LG. (1999). Effect of styrene on monoamine oxidase B activity in rat brain. J Toxicol Environ Health, Part A, 56, 59–68.
  • COM. (1999). 706. Communication from the Commission – Community strategy for Endocrine Disrupters.
  • Cruzan G, Cushman JR, Andrews LS, Granville CC, Miller RR, Hardy CJ, et al. (1997). Subchronic inhalation studies of styrene in CD rats and CD-1 mice. Fund Appl Toxicol, 35, 152–65.
  • Cruzan G, Cushman JR, Andrews LS, Granville GC, Johnson KA, Hardy C, et al. (1998). Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks. Toxicol Sci, 46, 266–81.
  • Cruzan G, Cushman JR, Andrews LS, Granville GC, Johnson KA, Bevan C, et al. (2001). Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J Appl Toxicol, 21, 185–98.
  • Cruzan G, Faber WD, Johnson KA, Roberts LS, Hellwig J, Carney E, et al. (2005a). Two generation reproduction study of styrene by inhalation in Crl-CD rats. Birth Defects Res (Part B), 74, 211–20.
  • Cruzan G, Faber WD, Johnson KA, Roberts LS, Hellwig J, Maurissen J, et al. (2005b). Developmental neurotoxicity study of styrene by inhalation in Crl-CD rats. Birth Defects Res (Part B), 74, 221–32.
  • CSTEE. (2000). Opinion on BKH Consulting Engineers Report “Towards the establishment of a priority list of substances for further evaluation of their role in endocrine disruption” - Opinion adopted at the 17th CSTEE plenary meeting, Brussels, September 5, 2000.
  • Date K, Ohno K, Azuma Y, Hirano S, Kobayashi K, Sakurai Y, et al. (2002). Endocrine-disrupting effects of styrene oligomers that migrated from polystyrene containers into food. Food Chem Toxicol, 40, 65–75.
  • de Peyster A, Mihaich E. (2014). Hypothesis-driven weight of evidence analysis to determine potential endocrine activity of MTBE. Reg Toxicol Pharmacol, 69, 348–70.
  • EC (European Commission). (1997). Proceedings of the European workshop on the impact of endocrine disrupters on human health and wildlife. Weybridge, UK. Available from http://ec.europa.eu/environment/chemicals/pdf/workshop_report.pdf
  • ECHA. (2010). Practical guide 2: how to report weight of evidence. European Chemicals Agency Helsinki, Finlande.
  • EFSA. (2013). Scientific Opinion on the hazard assessment of endocrine disruptors: Scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA Journal, 11, 3132
  • Egashira T, Takayama F, Sakai K, Yamanaka Y. (2000). Styrene inhibits monoamine oxidase A, but not monoamine oxidase B in monkey brain mitochondria. Toxicol Letters, 117, 115–19.
  • EHC 26. (1983). International Program on Chemical Safety; Environmental Health Criteria; Styrene
  • Evans R, Kortenkamp A, Martin O, McKinlay R, Orton F, Rosivatz E. (2011). State of the art assessment of endocrine disruptors; 2nd interim report, part1 summary of the state of science, project contract number 070307/2009/5506867/SER/D3. Draft 31.01.2011, p.. 290.
  • Fava M, Guaraldi G. (1987). Prolactin and stress. Stress Med, 3, 211–16.
  • Fegert I. (2013). ECETOC florence workshop on risk assessment of endocrine substances, including the potency concept. Toxicol Lett, 223, 310–14.
  • Freeman ME, Kanyicska B, Lerant A, Nagy G. (2000). Prolactin: Structure, function and regulation of secretion. Physiol Rev, 80, 1523–612.
  • Fu MH, Alexander M. (1992). Biodegradation of styrene in samples of natural environments. Environ Sci Technol, 26, 1540–4.
  • Gagnaire F, Chalansonnet M, Carabin N, Micillino JC. (2006). Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain. Arch Toxicol, 80, 703–12.
  • Grossi G, Theorell T, Jurisoo M, Setterlind S. (1999). Psychophysiological correlates of organizational change and threat of unemployment among police inspectors. Integr Physiol Behav Sci, 34, 30–42.
  • Herzog CJ, Czeh B, Corbach S, Wuttke W, Schulte-Herbruggen O, Hellweg R, et al. (2009). Chronic social instability stress in female rats: a potential animal model for female depression. Neuroscience, 159, 982–92.
  • Hillefors-Berglund M, Liu Y, von Euler G. (1995). Persistent, specific and dose-dependent effects of toluene exposure on dopamine D2 agonist binding in the rat caudate-putamen. Toxicology, 100, 185–94.
  • Husain R, Srivastava SP, Mushtaq M, Seth PK. (1980). Effect of styrene on levels of serotonin, noradrenaline, dopamine and activity of acetyl cholinesterase and monoamine oxidase in rat brain. Toxicol Lett, 7, 47–50.
  • Husain R, Srivastava SP, Seth PK. (1985a). Some behavioral effects of early styrene intoxication in experimental animals. Arch Toxicol, 57, 53–5.
  • Husain R, Zaidi F, Srivastava SP, Seth PK. (1985b). Effect of styrene oxide on levels of biogenic amines and activity of monoamine oxidase in different parts of the rat brain. Bull Environ Contam Toxicol, 34, 722–9.
  • IARC. (2002). Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 82: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Lyon, France.
  • Ippolitio F, Canitano N, De Santis W, Longo M. (2002). Women and Stress: influence of psychological status on immunity. Acta Med Rom, 40, 286–94.
  • Ivanova-Tchemichanska L, Antov G, Ilieva P. (1982). [Gonadotropic action of some organic solvents]. In: Resumes de la XVIIe Semaine, August 29-September 3, 1982, Sofia, Bulgaria, Sofia L. Union Médicale Balkanique, pp. 50–1 (in French).
  • Izjumova AS. (1972). [The action of small concentrations of styrol on the sexual function of albino rats]. Gig i Sanit, 37, 29–30. (in Russian).
  • Jarry H, Metten M, Gamer AO, Wuttke W. (2002). Effects of 5-day styrene inhalation on serum prolactin and dopamine levels and on hypothalamic and striatal catecholamine concentrations in male rats. Arch Toxicol, 76, 657–63.
  • Jarry H, Gamer AO, Wuttke W. (2004). Effects of 5-day styrene inhalation on serum LH and T levels and on hypothalamic and striatal amino acid neurotransmitter concentrations in male rats. Inhal Toxicol, 16, 209–15.
  • Kanada M, Miyagawa M, Sato M, Hasegawa H, Honma T. (1994). Neurochemical profile of effects of 28 neurotoxic chemicals on the central nervous system in rats (1) effects of oral administration on brain contents of biogenic amines and metabolites. Ind Health, 32, 145–64.
  • Katakura, Y, Kishi, R, Ikeda, T, Miyake, H. (1999). Effects of prenatal exposure to styrene on neurochemical levels in rat brain. Toxicol Lett, 105, 239–49
  • Katakura Y, Kishi R, Ikeda T, Miyake H. (2001). Effects of prenatal styrene exposure on postnatal development and brain serotonin and catecholamine levels in rats. Environ Res Section A, 85, 41–7.
  • Khanna VK, Husain R, Hanig JP, Seth PK. (1991). Increased neurobehavioral toxicity of styrene in protein-malnourished rats. Neurotoxicol Teratol, 13, 152–9.
  • Khanna VK, Husain R, Seth PK. (1994). Effect of protein malnutrition on the neurobehavioral testing of styrene in young rats. J Appl Toxicol, 14, 351–6.
  • Kishi R, Katakura Y, Ikeda T, Chen BQ, Miyake H. (1992). Neurochemical effects in rats following gestational exposure to styrene. Toxicol Lett, 63, 141–6.
  • Klinefelter GR, Laskey JW, Roberts NL. (1991). In vitro/in vivo effects of ethane dimethanesulfonate on Leydig cells in adult rats. Toxicol Appl Pharmacol, 107, 460–71.
  • Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T. (2002). Risk factors for goiter and thyroid nodules. Thyroid, 12, 879–88.
  • Kurume Laboratory. (2005). Daphnia magna Reproduction Study of Styrene. Unpublished. Testing laboratory: Kurume Laboratory Chemicals Evaluation and Research Institute, Japan. Report no.: 93603. Owner: Japan Styrene Industry Association; Styrene REACh consortium. Report date: 2005–06-21. (A robust summary of the study can be accessed at the ECHA database of registered substances: http://echa.europa.eu/web/guest/information-on-chemicals/registered-substances)
  • Kuwada M, Kawashima R, Nakamura K, Kojima H, Hasumi H, Maki J, Sugano S. (2002). Neonatal exposure to endocrine disruptors suppresses juvenile testis weight and steroidogensis but spermatogenesis is considerably restored during puberty. Biochem Biophys Res Commun, 295, 193–7.
  • Kuwada M, Kawashima R, Nakamura K, Hasumi H, Maki J. (2012). Study of the neonatal exposure to estrogenic and androgenic endocrine disruptors by normal-phase HPLC. Drug Delivery Letters, 2, 126–31.
  • Ladefoged O, Lam HR, Ostergaard G, Hansen EV, Hass U, Lund SP, Simonsen L. (1998). Toxicity of the styrene metabolite, phenylglyoxylic acid, in rats after 3 months’ oral dosing. NeuroToxicology, 19, 721–38.
  • Lennartsson AK, Jonsdottir IH. (2011). Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology, 36, 1530–9.
  • Li B, Xiao JW, Wang HH, Li ZS, et al. (2006). Effects of styrene on the dopaminergic transmitter content and monoamine oxidase activity in different sections of rat brain. J Hyg, 35, 399–401.
  • Lökk J, Arnetz B. (1997). Psychophysiological concomitants of organizational change in health care personnel: effects of a controlled intervention study. Psychotherapy Psychosomatics, 66, 74–7.
  • Luderer U, Tornero-Velez R, Shay T, Rappaport S, Heyer N, Echeverria D. (2004). Temporal association between serum prolactin concentration and exposure to styrene. Occup Environ Med, 61, 325–33.
  • Luderer U, Collins TFC, Daston GP, Fischer LJ, Gray RH, Mirer FE, et al. (2005). NTP-CERHR expert panel report on the reproductive and developmental toxicity of styrene. Birth Defects Res (Part B), 77, 110–93.
  • Malarkey WB, Kiecolt-Glaser JK, Pearl D, Glaser R. (1994). Hostile behaviour during martial conflict alters pituitary and adrenal hormones. Psycosomatic Med, 56, 41–51.
  • McKinney J, Fannin R, Jordan S, Chae K, Rickenbacher U, Pedersen L. (1987). Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts. J Med Chem, 30, 79–86.
  • Meyerhoff JL, Oleshansky MA, Mougey EH. (1988). Psychological stress increases plasma levels of prolactin, cortisol, and POMC-derived peptides in man. Psychosomatic Med, 50, 295–303.
  • Murray FJ, John JA; Balmer MF; Schwetz BA. (1978). Teratologic evaluation of styrene given to rats and rabbits by inhalation or by gavage. Teratology, 11, 335–43.
  • Mutti A, Vescovi PP, Falzio M, Arfini G, Valenti G, Franchini I. (1984a). Neuroendocrine effects of styrene on occupationally exposed workers. Scand J Work Environ Health, 10, 225–8.
  • Mutti A, Falzio M, Romanelli A, Franchini I. (1984b). Regional alterations of brain catecholamines by styrene exposure in rabbits. Arch Toxicol, 55, 173–7.
  • Mutti A, Romanelli A, Falzio M, Lucertini S, Franchini I. (1985). Styrene metabolism and striatal dopamine depletion in rabbits. Arch Toxicol Suppl, 8, 447–50.
  • Mutti A, Falzio M, Romanelli A, Bocchi MC, Ferroni C, Franchini I. (1988). Brain dopamine as a target for solvent toxicity: effects of some monocyclic aromatic hydrocarbons. Toxicology, 49, 77–82.
  • Mutti A. (1988). Styrene exposure and serum prolactin. J Occup Med, 30, 481–2.
  • Neill JD. (1988). Prolactin secretion and its control. In: Knobil E, Neill J (eds). The physiology of reproduction. Chapter 33, Prolactin secretion and its control. Raven Press, New York, pp 1379–1390
  • Nishihara T, Nishikawa J, Kanayama T, Dakeyama F, Saito K, Imagawa M, et al. (2000). Estrogenic activity of 517 chemicals by yeast two-hybrid assay. J Health Sci, 46, 282–98
  • Nobuhara Y, Hirano S, Azuma Y, Date K, Ohno K, Tanaka K, et al. (1999). Biological evaluation of styrene oligomers for endocrine-disrupting effects. J Food Hygiene Soc Japan, 40, 36–45.
  • Noel GL, Suh HK, Stone JG, Frantz AG. (1972). Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab, 35, 840–51.
  • NTP. (2006). NTP-CERHR Monograph on the potential human reproductive and developmental effects of styrene. National Toxicology Program; U.S. Department of Health and Human Services. NIH Publication No. 06–4475.
  • OECD. (2006). Detailed review paper on thyroid hormone disruption assays. OECD series on testing and assessment No 57. ENV/JM/MONO(2006)24.
  • OECD. (2012). Guidance document on standardised test guidelines for evaluating chemicals for endocrine disruption. Series on testing and assessment. No 150. 24-Aug-2012. ENV/JM/MONO (2012)22.
  • Ohno K, Azuma Y, Nakano S, Kobayashi T, Hirano S, Nobuhara Y, Yamada T. (2001). Assessment of styrene oligomers eluted from polystyrene-made food containers for estrogenic effects in in vitro assays. Food Chem Toxicol, 39, 1233–41.
  • Ohtani H, Ichikawa Y, Iwamoto E, Miura I. (2001). Effects of styrene monomer and trimer on gonadal sex differentiation of the frog Rana rugosa. Environ Res Section A, 87, 175–80.
  • Oliveira MC, Pizarro CB, Golbert L, Micheletto C. (2000). [Hyperprolactinemia and psychological disturbance]. Arq Neuropsiquiatr, 58, 671–6.
  • Quast JF, Kalins RP, Olson KJ, Humiston CG, Murray FJ, John JA, Schwetz BA. (1978). Results of a toxicity study in dogs and teratogenicity studies in rabbits and rats administered monomeric styrene. In: Meeting of the Society of Toxicology. San Francisco, USA, March 1978.
  • RAC. (2012). Committee for Risk Assessment. Opinion proposing harmonised classification and labelling at the EU level of styrene. Adopted 28 November 2012.
  • Ramsey, JC, Young, JD. (1978). Pharmacokinetics of inhaled styrene in rats and humans. Scand J Work Environ Health, 4 (Suppl. 2), 84–91.
  • Reichlin S. (1988). Prolactin and growth hormone secretion in stress. Adv Exp Med Biol, 245, 353–76.
  • Rhomberg LR, Bailey LA, Goodman JE. (2010). Hypothesis-based weight of evidence: A tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action - naphthalene as an example. Crit Rev Toxicol, 40, 671–96
  • Rhomberg LR, Goodman JE, Bailey LA, Prueitt RL, Beck NB, Bevan C, et al. (2013). A survey of frameworks for best practices in weight-of-evidence analyses. Crit Rev Toxicol, 43, 753–84.
  • Romanelli A, Falzio M, Mutti A, Bergamaschi E, Franchini I. (1986). Effects of some monocyclic aromatic solvents and their metabolites on brain dopamine in rabbits. J Appl Toxicol, 6, 431–5.
  • Ruiz P, Ortiz-Zarragoitia M, Orbea A, Theron M, Le Floch S, Cajaraville MP. (2012). Responses of conventional and molecular biomarkers in turbot Scophthalmus maximus exposed to heavy oil no. 6 and styrene. Aquatic Toxicology, 116–117, 116–28.
  • Ruiz P, Ortiz-Zarragoitia M, Orbea A, Vingen S, Hjelle A, Baussant T, Cajaraville MP. (2014). Short- and long-term responses and recovery of mussels Mytilus edulis exposed to heavy oil no. 6 and styrene. Ecotoxicology, 23, 861–79.
  • Santini F, Mantovani A, Cristaudo A, Rago T, Marsili A, Buselli R, et al. (2008). Thyroid function and exposure to styrene. Thyroid, 18, 1065–9.
  • Schapira M, Raaka BM, Das S, Fan L, Totrov M, Zhou Z, et al. (2003). Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proc Natl Acad Sci USA, 100, 7354–9
  • Schedlowski M, Wiechert D, Wagner TOF, Tewes U. (1992). Acute psychological stress increases plasma levels of cortisol, prolactin and TSH. Life Sci, 50, 1201–5.
  • SCCS (Scientific Committee on Consumer Safety). (2014). Memorandum on endocrine disruptors. SCCS/1544/14, 16 December 2014. Available at http://ec.europa.eu/health/scientific_committees/consumer_safety/index_en.htm
  • SEC. (2004). 1372 Commission staff working document on the implementation of the Community Strategy for Endocrine Disrupters – a range of substances suspected of interfering with the hormone systems of humans and wildlife.
  • SEC. (2007).1635: Commission staff working document on the implementation of the Community Strategy for Endocrine Disrupters – a range of substances suspected of interfering with the hormone systems of humans and wildlife.
  • Seggie JA, Brown GM. (1975). Stress response patterns of plasma corticosterone, prolactin, and growth hormone in the rat, following handling or exposure to novel environment. Can J Physiol Pharmacol, 53, 629–637.
  • Sinitskij VG. (1969). [Indexes for immunological reactivity in rabbits during the long-term exposure to small doses of styrene]. Gig Primen Polim Mater Izdelii Nikh, 1, 394–8. (in Russian).
  • Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. (1995). The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect, 103 (Suppl. 7), 113–22.
  • Srivastava S, Seth PK, Srivastava SP. (1989). Effects of styrene administration on rat testis. Arch Toxicol, 63, 43–6.
  • Srivastava S, Seth PK, Srivastava SP. (1992a). Effects of styrene on testicular enzymes of growing rat. Indian J Exp Biol, 30, 399–401.
  • Srivastava S, Seth PK, Srivastava SP. (1992b). Biochemical and morphological studies in testes of rat offspring of mothers exposed to styrene during lactation. Pharmacol Toxicol, 70, 314–16.
  • Steinmetz R, Brown NG, Allen DL, Bigsby RM, Ben-Jonathan N. (1997). The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology, 138, 1780–6
  • Stump DG. (2003). An inhalation two-generation reproductive toxicity study of styrene in rats including developmental neurotoxicity assessment of the F2 generation. WIL Reserch Laboratories. Study No. WIL-419002.
  • Szawka RE, Podovalho GV, Helena CVV, Franci CR, Anselmo-Franci JA. (2007). Prolactin secretory surge during estrous coincides with increased dopamine activity in the hypothalamus and preoptic area and is not altered by ovariectomy on proestrous. Brain Res Bull, 73, 127–34.
  • Takao T, Nanamiya W, Nazarloo HP, Sasaba K, Hashimoto K. (2000). Possible reproductive toxicity of styrene in peripubertal male mice. Endocrine J, 47, 343–7.
  • Tatarazako N, Takao Y, Kishi K, Onikura N, Arizono K, Iguchi T. (2002). Styrene dimers and trimers affect reproduction of daphnid (ceriodaphnia dubia). Chemosphere, 48, 597–601.
  • Taya K, Igarashi, M. (1973). Changes in FSH, LH and prolactin secretion during estrous cycle in rats. Endocrinol Jpn, 20, 199–205.
  • Theorell T, Perski A, Akerstedt T, Sigala F, Ahlberg-Hulten G, Svensson J, Eneroth P. (1988). Changes in job strain in relation to changes in physiological state. Scand J Work Environ Health, 14, 189–96.
  • Theorell T, Ahlberg-Hulten G, Sigala F, Perski A, Soderholm M, Kallner A, Eneroth P. (1990). A psychosocial and biomedical comparison between men in six contrasting service occupations. Work Stress, 4, 51–63.
  • Theorell T, Ahlberg-Hulten G, Jodko M, Sigala F, de la Torre B. (1993). Influence of job strain and emotion on blood pressure in female hospital personnel during workhours. Scand J Work Environ Health, 19, 313–18.
  • Uhart M, Oswald L, McCaul ME, Chong R, Wand GS. (2006). Hormonal responses to psychological stress and family history of alcoholism. Neuropsychopharmacology, 31, 2255–63.
  • UK RAR. (2008). European Union Risk Assessment Report, Styrene. Draft for publication, June 2008. United Kingdom.
  • Umemura T, Kurahashi N, Kondo T, Katakura Y, Sata F, Kawai T, Kishi R. (2005). Acute effects of styrene inhalation on the neuroendocrinological system of rats and the different effects in male and female rats. Arch Toxicol, 79, 653–9.
  • US EPA. (1994). Short term methods for estimating the chronic toxicity of effluents and receiving waters to fresh water organisms (third ed.). US Environmental Protection Agency, Report EPA/600/4–91/003. Office of Research and Development, Cincinatti, USA.
  • Von Euler G, Bjornas S. (1990). Persistent effects of chronic exposure to styrene on the affinity of neostriatal dopamine D-2 receptors. Toxicol Lett, 54, 101–6.
  • WHO/IPCS (World Health Organization/International Programme on Chemical Safety). (2002). Global assessment of the state-of-the-science of endocrine disruptors. WHO/IPCS/EDC/02.2.
  • Yamada T. (1999). Synthesis, analysis and biological evaluation of styrene oligomers. Yuki Goseikagaku Kyokaishi, 57, 58–64.
  • Zaidi NF, Agrawal AK, Srivastava SP, Seth PK. (1985a). Effect of styrene oxide on dopamine receptors in rats. Bull Environ Contam Toxicol, 35, 602–7.
  • Zaidi NF, Agrawal AK, Srivastava SP, Seth PK. (1985b). Effect of gestational and neonatal styrene exposure on dopamine receptors. Neurobehav Toxicol Teratol, 7, 23–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.